SPOTLIGHT: Judge says Wyeth's not liable


A federal appeals court ruled in favor of Wyeth in the case of a Little Rock woman who developed breast cancer while taking the company's hormone replacement therapy, Premarin and Prempro. The court upheld a jury's verdict that Wyeth wasn't liable. Report

Suggested Articles

It's taken years for Amarin's Vascepa to prove itself as a game-changing treatment for CV disease. An FDA committee may have just punched its pass.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

With a potential approval next year in the up-and-coming NASH field, Intercept is staffing up its sales team and starting talks with payers.